1. Wu, Zhenzhen, Wang, Yueyuan, Li, Juan, Tuo, Xunyuan, Zheng, Jing. 2022. MCM10 is a Prognostic Biomarker and Correlated With Immune Checkpoints in Ovarian Cancer. In Frontiers in genetics, 13, 864578. doi:10.3389/fgene.2022.864578. https://pubmed.ncbi.nlm.nih.gov/35664337/
2. Tian, Qiu-Si, Zhang, Qun, Huang, Wei. . MCM10 as a novel prognostic biomarker and its relevance to immune infiltration in gliomas. In Technology and health care : official journal of the European Society for Engineering and Medicine, 31, 1301-1317. doi:10.3233/THC-220576. https://pubmed.ncbi.nlm.nih.gov/36872806/
3. Chen, Dengwang, Zhong, Na, Guo, Zhanwen, He, Yuqi, Song, Tao. 2023. MCM10, a potential diagnostic, immunological, and prognostic biomarker in pan-cancer. In Scientific reports, 13, 17701. doi:10.1038/s41598-023-44946-2. https://pubmed.ncbi.nlm.nih.gov/37848534/
4. Reubens, Michael C, Biller, Megan D, Bedsole, Sidney E, Ables, Elizabeth T, Christensen, Tim W. 2015. Mcm10 is required for oogenesis and early embryogenesis in Drosophila. In Mechanisms of development, 138 Pt 3, 291-9. doi:10.1016/j.mod.2015.09.002. https://pubmed.ncbi.nlm.nih.gov/26369283/
5. Schmit, Megan M, Baxley, Ryan M, Wang, Liangjun, Miller, Jeffrey S, Bielinsky, Anja-Katrin. 2024. A critical threshold of MCM10 is required to maintain genome stability during differentiation of induced pluripotent stem cells into natural killer cells. In Open biology, 14, 230407. doi:10.1098/rsob.230407. https://pubmed.ncbi.nlm.nih.gov/38262603/